A faculty member in the Department of Pharmaceutical Sciences (PSC) is using novel computational modeling technologies to improve the efficacy of treatments for lung diseases like asthma and chronic obstructive pulmonary disease (COPD).
In a recently published article in Proceedings of the National Academy of Sciences, Alexander MacKerell, PhD, the Grollman-Glick Professor of Pharmaceutical Sciences and director of the Computer-Aided Drug Design (CADD) Center at the University of Maryland School of Pharmacy, details translational research using computational methods to identify a new binding site for drug therapy along with compounds that bind to that site with the potential to be developed into new therapeutics.
Read the full story on the School of Pharmacy's News Center.